Polyamine Metabolism as a Metabolic Vulnerability in Prostate Cancer Treated with Supraphysiological Androgens. Alizadeh-Ghodsi M, Goldstein AS. Cancer Res 2026;86:1095-1097.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Alizadeh-Ghodsi M, Goldstein AS. Polyamine Metabolism as a Metabolic Vulnerability in Prostate Cancer Treated with Supraphysiological Androgens. Cancer Res 2026;86:1095-1097.
PMID: 41766411